Equites Radar

CHE · Chemed Corp

Medical Care FacilitiesUnited StatesAnalyst view: none

$515.97

+0.30% last session

End-of-day data · close of 2026-09-11

Neutral2 bullish · 2 bearish technical signals
To mean target: +7.3%

Market cap

$7B

Enterprise value

$7B

Trailing P/E

25.9

Forward P/E

18.7

Dividend yield

1.0%

Beta

0.51

Avg volume

0M

Employees

16K

Daily Change %

0.30%

5 Days Change

-0.24%

10 Days Change

-0.03%

30 Days Change

-3.33%

60 Days Change

6.28%

Month to Day Change

0.66%

Year to Day Change

21.68%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts4
Mean price target$552.00
Low price target$520.00
Upside to mean target+7.3%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)44.2
50-day MA$519.80
200-day MA$448.40
Price vs 50-day MA-0.7%
Price vs 200-day MA+15.1%
MACD histogram-2.95
Volume vs 3-month avg0.5×
52w low $367.6052w high $551.99

Analyst sentiment over time — CHE

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-31

Latest call per bank · past 12 months

RBC Capital

Sector Perform

$548

+6.5% vs price
▲ raised from $436Maintains · 2026-07-30

Bank of America

Neutral

$510

-0.9% vs price
▲ raised from $450Maintains · 2026-07-09

Jefferies

Hold

$475

-7.7% vs price
▼ cut from $550Downgrade · 2026-01-22

Recent rating actions

DateFirmActionRatingPrice target
2026-07-31OppenheimerMaintainsOutperform$500 $590
2026-07-30RBC CapitalMaintainsSector Perform$436 $548
2026-07-09Bank of AmericaMaintainsNeutral$450 $510
2026-04-27RBC CapitalMaintainsSector Perform$422 $436
2026-02-27RBC CapitalDowngradeOutperformSector Perform$572 $422
2026-02-27OppenheimerMaintainsOutperform$580 $500
2026-01-22JefferiesDowngradeBuyHold$550 $475
2025-11-10RBC CapitalMaintainsOutperform$589 $572

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 44 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 0.7% below the 50-day MA ($519.80).
  • Price vs 200-day MA: Trading 15.1% above the 200-day MA ($448.40).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-2.95) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($367.60) and high ($551.99).

CHE Price Chart

Loading chart for CHE

Fundamentals

Revenue (TTM)$3.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$63.81
Net Debt / EBITDA0.6
WACC8.0%
Revenue growth9.00%
Earnings growth44.00%

About Chemed Corp

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

More in Medical Care Facilities

Screen CHE against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.